Trial Information

Summary: New Investigational Anti-HIV Drug

This study investigates the ability of a CCR5 receptor blocker, in combination with Optimized Background Therapy (OBT), to decrease the level of HIV virus (viral load) in the blood of study volunteers

Patient Inclusion Criteria

• HIV-1 positive adults at least 18 years of age,
• HIV-1 RNA greater than 1000 copies/mL within last 2 months either on a stable regimen of 3 or more antiretroviral drugs for at least 4 weeks at screening or not on any antiretroviral drugs for at least 4 weeks before screening.

Patient Exclusion Criteria

• No detectable CXCR4-tropic or dual/mixed CCR5/CXCR4-tropic HIV isolates at screening.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:32:50 AM